Novartis Aktie
101,26
EUR
-0,04
EUR
-0,04
%
94,21
CHF
+0,42
CHF
+0,45
%
Werbung
Novartis Aktie Analyse
19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.07.17 | Novartis Hold | Deutsche Bank AG | |
18.07.17 | Novartis Hold | S&P Capital IQ | |
18.07.17 | Novartis Neutral | UBS AG | |
17.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.07.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
Werbung
|
|||
10.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
07.07.17 | Novartis Hold | Deutsche Bank AG | |
23.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
23.06.17 | Novartis Equal weight | Barclays Capital | |
23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.06.17 | Novartis Hold | Deutsche Bank AG | |
21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
24.05.17 | Novartis Neutral | UBS AG | |
19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
26.04.17 | Novartis Hold | Deutsche Bank AG | |
25.04.17 | Novartis Hold | S&P Capital IQ | |
21.04.17 | Novartis Neutral | UBS AG | |
18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
11.04.17 | Novartis Hold | Deutsche Bank AG | |
06.04.17 | Novartis Neutral | UBS AG | |
23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.03.17 | Novartis Hold | Deutsche Bank AG | |
15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.03.17 | Novartis Neutral | UBS AG | |
10.03.17 | Novartis Hold | Deutsche Bank AG | |
06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
30.01.17 | Novartis Neutral | UBS AG | |
26.01.17 | Novartis Hold | Deutsche Bank AG | |
25.01.17 | Novartis Hold | S&P Capital IQ | |
24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
09.01.17 | Novartis Hold | Deutsche Bank AG |
Werbung
Werbung